Incidence of arrhythmic events in patients with implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death

Swiss Medical Weekly

Volumn 134, Issue 11-12, 2004, Pages 154-158

  Capoferri, Mauro ^a   Schwick, Nicola ^a   Tanner, Hildi ^a   Fuhrer, Jürg ^a   Delacretaz, Etienne ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Implantable defibrillator; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; SECONDARY PREVENTION; SUDDEN DEATH;

EID: 1842454771     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
4. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342:365-373.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
6. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. Circulation 2002;106:2145-61.
7. Prystowsky E. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator. Rev Cardiovasc Med 2003;4(Suppl2): S47-54.
8. Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant C, et al. Effectiveness of Implantable Defibrillators for Preventing Arrhythmic Events and Death: A Meta-Analysis. J Am Coll Cardiol 2003;41:1573-82.
9. Abildstrom SZ, Torp-Pedersen C, Kober L. Implication of MADIT-II on unselected patients following an acute myocardial infarction (abstr). J Am Coll Cardiol 2003; 41 Suppl A.